Sophiris Bio, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net loss before income taxes of $8,750,000 against $2,642,000 a year ago. Net loss was $8,750,000 or $0.53 per basic and diluted share against $2,642,000 or $0.84 per basic and diluted share a year ago.

For the six months, the company reported net loss before income taxes of $17,209,000 against $2,258,000 a year ago. Net loss was $17,209,000 or $1.05 per basic and diluted share against $2,758,000 or $0.88 per basic and diluted share a year ago.